dehydroepiandrosterone has been researched along with Hyperparathyroidism in 3 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandenburg, VM | 1 |
| Ketteler, M | 1 |
| Heussen, N | 1 |
| Politt, D | 1 |
| Frank, RD | 1 |
| Westenfeld, R | 1 |
| Ittel, TH | 1 |
| Floege, J | 1 |
| Almqvist, EG | 1 |
| Becker, C | 1 |
| Bondeson, AG | 1 |
| Bondeson, L | 1 |
| Svensson, J | 1 |
| Barna, I | 1 |
| Váradi, A | 1 |
| Lakatos, P | 1 |
3 other studies available for dehydroepiandrosterone and Hyperparathyroidism
| Article | Year |
|---|---|
Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Dehydroepiandrosterone; Estradiol; Female; Foll | 2005 |
Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.
Topics: Aged; Aged, 80 and over; Biological Availability; Bone Density; Calcium; Dehydroepiandrosterone; Est | 2006 |
Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment.
Topics: Cardiovascular Diseases; Dehydroepiandrosterone; Humans; Hyperparathyroidism; Parathyroid Hormone; R | 1999 |